Vivo Capital, LLC Io Biotech, Inc. Transaction History
Vivo Capital, LLC
- $512 Million
- Q4 2024
A detailed history of Vivo Capital, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 6,173,439 shares of IOBT stock, worth $6.85 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
6,173,439
Previous 6,173,439
-0.0%
Holding current value
$6.85 Million
Previous $6.48 Million
12.39%
% of portfolio
1.11%
Previous 0.95%
Shares
2 transactions
Others Institutions Holding IOBT
# of Institutions
26Shares Held
19.7MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G73.35MShares$3.72 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.6 Million0.14% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$2.34 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.65MShares$1.83 Million0.0% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA864KShares$959,2580.73% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $32M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...